COMSECY-20-0001, VR-COMSECY-20-0001: Renewal of Advisory Committee on the Medical Uses of Isotopes (ACMUI) Charter: Difference between revisions

From kanterella
Jump to navigation Jump to search
(StriderTol Bot change)
(StriderTol Bot change)
 
Line 1: Line 1:
#REDIRECT [[COMSECY-20-0001, Enclosure 2 - United States Nuclear Regulatory Commission Charter for the Advisory Committee on the Medical Uses of Isotopes (Redlines)]]
{{Adams
| number = ML20035D215
| issue date = 01/31/2020
| title = VR-COMSECY-20-0001: Renewal of Advisory Committee on the Medical Uses of Isotopes (ACMUI) Charter
| author name = Commissioners
| author affiliation = NRC/OCM
| addressee name = Vietti-Cook A
| addressee affiliation = NRC/SECY
| docket =
| license number =
| contact person =
| case reference number = COMSECY-20-0001
| document report number = VR-COMSECY-20-0001
| document type = Commission Voting Record (CVR)
| page count = 12
}}
 
=Text=
{{#Wiki_filter:f RESPONSE SHEET TO:                    Annette Vietti-Cook, Secretary FROM:                  CHAIRMAN SVINICKI
 
==SUBJECT:==
COMSECY-20-0001: Renewal of Advisory Committee on Medical Isotopes (ACMUI) Charter Approved XX              Disapproved_ Abstain _                    Not Participating _
Comments:          Below XX            Attached XX              None I approve the renewal of the charter of the Advisory Committee on the Medical Uses of Isotopes, subject to the additional edits reflected in the attached version .
01,Z J ,2020 DATE Entered on "STARS" Yes __L_ No_
 
KLS Edits        UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES
: 1. Committee's Official Designation {Title):
Advisory Committee on the Medical Uses of Isotopes (Committee or ACMUI)
: 2. Authority:
The committee is established pursuant to 42 United States Code (U .S.C) §2201 as an NRC discretionary committee in accordance with the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App.
: 3. Objectives and Scope of Activities:
The Committee provides advice, as requested by the Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST), Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy.
: 4. Description of Duties:
The Committee comments on changes to NRC regulations and guidance; evaluates certain non-routine uses of radioactive material; provides technical assistance in licensing, inspection, and enforcement cases; and brings key issues to the attention of the agency for appropriate action. The Committee members may also serve as medical consultants to the Director, MSST, as requested.
: 5. Official to Whom this Committee Reports:
Director, Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington , DC 20555
: 6. Agency Responsible for Providing Necessary Support to this Committee:
U.S. Nuclear Regulatory Commission.
: 7. Estimated Annual Operating Costs and Staff Years:
Approximately 13 members utilize 1.84 FTE (includes approximately 1.13 FTE in NRC staff support and 0.71 FTE for ACMUI member compensation and travel expenses), and
      $337,000.
: 8. Designated Federal Officer:
A full time NRC employee from the Division of Materials Safety, Security, State, and Tribal Programs will serve as the Designated Federal Officer (DFO). The DFO will
 
approve or call all of the advisory committee and subcommittee meetings, prepare and approve all meeting agendas, attend all committee and subcommittee meetings, adjourn any meeting when the DFO determines adjournment to be in the public interest, and chair meetings when directed to do so by the Director, MSST.
: 9. Estimated Number of Meetings per Year:
Approximately five meetings per year, three of which are teleconferences.
: 10. Duration:
Continuing Committee
: 11. Termination:
Unless renewed by appropriate action, the Committee will terminate two-years from the date this charter is filed.
: 12. Membership and Designation:
Members are appointed by the Director, NMSS as Special Government Employees. The membership of the Committee +s-comprise.§.a approximatelyef 13 members, including health care professionals of diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration , and patient care advocacy.
: 13. Subcommittees:
The Committee may create subcommittees that report to the full committee. The Committee does not have standing subcommittees; if ad hoc subcommittees are used, they would report to the full Committee.
: 14. Recordkeeping:
The Committee records will be handled in accordance with General Records Schedule 6.2 and approved NRC records disposition schedules. These records shall be available for public inspection and copying, subject to the Freedom of Information Act, 5 U.S.C.
552.
: 15. Filing date:
Month XX, 2020 Russell E. Chazell Federal Advisory Committee Management Officer Office of the Secretary
 
RESPONSE SHEET TO:                    Annette Vietti-Cook, Secretary FROM:                  Commissioner Baran
 
==SUBJECT:==
COMSECY-20-0001: Renewal of Advisory Committee on Medical Isotopes (ACMUI) Charter Approved          X    Disapproved _ _ Abstain _ _ Not Participating COMMENTS:              Below        X    Attached          X    None I approve the renewal of the updated Advisory Committee on the Medical Uses of Isotopes charter for a period of two years , subject to the attached edits.
Entered in "STARS" Yes      X No DATE
 
UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON MEDICAL USES OF ISOTOPES
: 1. Committee's Official Designation (Title):
Advisory Committee on the Medical Uses of Isotopes (Committee or ACMUI}
: 2. Authority:
The committee is established pursuant to 42 United States Code (U .S.C) §2201 as an NRC discretionary committee in accordance with the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App.
: 3. Objectives and Scope of Activities:
The Committee provides advice, as requested by the Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST), Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy.
: 4. Description of Duties:
The Committee comments on changes to relevant NRC regulations and guidance; evaluates certain non-routine uses of radioactive material; provides technical assistance in licensing , inspection , and enforcement cases; and brings key issues to the attention of the agency for appropriate action . The Committee members may also serve as medical consultants to the Director, MSST, as requested .
: 5. Official to Whom this Committee Reports:
Director, Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington , DC 20555
: 6. Agency Responsible for Providing Necessary Support to this Committee:
U.S. Nuclear Regulatory Commission .
: 7. Estimated Annual Operating Costs and Staff Years:
Approximately 13 members utilize 1.84 FTE (includes approximately 1.13 FTE in NRC staff support and 0.71 FTE for ACMUI member compensation and travel expenses), and
  $337,000.
: 8. Designated Federal Officer:
A full time NRC employee from the Division of Materials Safety, Security, State, and Triba l Programs will serve as the Designated Federal Officer (DFO). The DFO will
 
approve or call all of the advisory committee meetings, prepare and approve all meeting agendas, attend all committee meetings, adjourn any meeting when the DFO determines adjournment to be in the public interest, and chair meetings when directed to do so by the Director, MSST.
: 9. Estimated Number of Meetings per Year:
Approximately five meetings per year, three of which are teleconferences.
: 10. Duration:
Continuing Committee
: 11. Termination:
Unless renewed by appropriate action, the Committee will terminate two-years from the date this charter is filed.
: 12. Membership and Designation:
Members are appointed by the Director, NMSS as Special Government Employees. The membership of the Committee is comprised of 13 members, including health care professionals of diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy.
: 13. Subcommittees:
The Committee does not have standing subcommittees; if ad hoc subcommittees are used, they would report to the full Committee.
: 14. Recordkeeping:
The Committee records will be handled in accordance with General Records Schedule 6.2 and approved NRC records disposition schedules. These records shall be available for public inspection and copying , subject to the Freedom of Information Act, 5 U.S.C.
552.
: 15. Filing date:
Month XX, 2020 Russell E. Chazell Federal Advisory Committee Management Officer Office of the Secretary
 
RESPONSE SHEET TO:                    Annette Vietti-Cook, Secretary FROM:                  Commissioner Caputo
 
==SUBJECT:==
COMSECY-20-0001: Renewal of Advisory Committee on Medical Isotopes (ACM UI) Charter Approved _XX_ Disapproved _                    Abstain _      Not Participating _
Comments:            Below        Attached _XX_ None I approve the updated charter for the Advisory Committee on the Medical Use of Isotopes, subject to the attached edits.
Entered in STARS Yes          X No DATE
 
AC Edits on COMSECY-20-0001 UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES
: 1. Committee's Official Designation (Title):
Advisory Committee on the Medical Uses of Isotopes (Committee or ACMUI)
: 2. Authority:
The committee is established pursuant to 42 United States Code (U.S.C) §2201 as an NRC discretionary committee in accordance with the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App.
: 3. Objectives and Scope of Activities:
The Committee serves in an advisory role and provides advice, as requested by the Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST),
Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy.
: 4. Description of Duties:
The Committee comments on changes to NRC regulations and guidance; evaluates certain non-routine uses of radioactive material; provides technical assistance in licensing, inspection, and enforcement cases; and brings key issues to the attention of the agency for appropriate action. The Committee members may also serve as medical consultants to the Director, MSST, as requested.
: 5. Official to Whom this Committee Reports:
Director, Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington, DC 20555
: 6. Agency Responsible for Providing Necessary Support to this Committee:
U.S. Nuclear Regulatory Commission.
: 7. Estimated Annual Operating Costs and Staff Years:
Approximately 13 members utilize 1.84 FTE (includes approximately 1, 13 FTE in NRC staff support and 0.71 FTE for ACMUI member compensation and travel expenses), and
      $337,000.
: 8. Designated Federal Officer:
 
A full time NRC employee from the Division of Materials Safety, Security, State, and Tribal Programs will serve as the Designated Federal Officer (DFO). The DFO will approve or call all of the advisory committee and subcommittee meetings, prepare and approve all meeting agendas, attend all committee and subcommittee meetings, adjourn any meeting when the DFO determines adjournment to be in the public interest, and chair meetings when directed to do so by the Director, MSST.
: 9. Estimated Number of Meetings per Year:
Approximately five meetings per year, three of which are teleconferences.
: 10. Duration:
Continuing Committee
: 11. Termination:
Unless renewed by appropriate action, the Committee will terminate two-years from the date this charter is filed.
: 12. Membership and Designation:
Members are appointed by the Director, NMSS as Special Government Employees. The membership of the Committee i&-comprise§.d approximately-et 13 members, including health care professionals of diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy.
: 13. Subcommittees:
The Committee does not have standing subcommittees, but has the authority to create subcommittees. which must report back to the full Committee and must not provide advice or work prod ucts directly to the agency. does not have standing subcommittees; if ad hoc subcommittees are used, they would report to the full Committee.
: 14. Recordkeeping:
The Committee records will be handled in accordance with General Records Schedule 6.2 and approved NRC records disposition schedules. These records shall be available for public inspection and copying, subject to the Freedom of Information Act, 5 U.S.C.
552.
: 15. Filing date:
Month XX, 2020 Russell E. Chazell Federal Advisory Committee Management Officer Office of the Secretary
 
RESPONSE SHEET TO:                  Annette Vietti-Cook, Secretary FROM:                  Commissioner Wright
 
==SUBJECT:==
COMSECY-20-0001: Renewal of Advisory Committee on Medical Isotopes (ACMUI) Charter Approved      _x__ Disapproved _            Abstain _    Not Participating _
Comments:          Below X          Attached      X  None I approve the renewal of the Advisory Committee on the Medical Uses of Isotopes charter for a period of two years, subject to the attached edits.
Entered in STARS Yes 7 No- - -
                                                      ~.cqJ SIGNATURE 01 /?.-'1-- /zo~o DATE              '
 
DAW Edits UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES
: 1. Committee's Official Designation (Title):
Advisory Committee on the Medical Uses of Isotopes (Committee or ACMUI)
: 2. Authority:
The committee is established pursuant to 42 United States Code (U.S.C) §2201 as an NRC discretionary committee in accordance with the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App.
: 3. Objectives and Scope of Activities:
The Committee provides advice, as requested by the Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST), Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy.
: 4. Description of Duties:
The Committee comments on changes to NRC regulations and guidance; evaluates certain non-routine uses of radioactive material; provides technical assistance in licensing, inspection, and enforcement cases; and brings key issues to the attention of the agency for appropriate action. The Committee members may also serve as medical consultants to the Director, MSST, as requested.
: 5. Official to Whom this Committee Reports:
Director, Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington, DC 20555
: 6. Agency Responsible for Providing Necessary Support to this Committee:
Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission.
: 7. Estimated Annual Operating Costs and Staff Years:
Approximately 13 members utilize 1.84 FTE (includes approximately 1.13 FTE in NRC staff support and 0.71 FTE for ACMUI member compensation and travel expenses), and
      $337,000.
: 8. Designated Federal Officer:
 
A full time NRC employee from the Division of Materials Safety, Security, State, and Tribal Programs will serve as the Designated Federal Officer (DFO). The DFO will approve or call all of the advisory committee and subcommittee meetings, prepare and approve all meeting agendas , attend all committee and subcommittee meetings, adjourn any meeting when the DFO determines adjournment to be in the public interest, and chair meetings when directed to do so by the Director, MSST.
: 9. Estimated Number of Meetings per Year:
Approximately five meetings per year, three of which are teleconferences.
: 10. Duration:
Continuing Committee
: 11. Termination:
Unless renewed by appropriate action, the Committee will terminate two-years from the date this charter is filed.
: 12. Membership and Designation:
Members are appointed by the Director, NMSS as Special Government Employees. The membership of the Committee is composedfisee of 13 members, including health care professionals of diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy.
: 13. Subcommittees:
The Committee does not have standing subcommittees. The full Committee may create~
    # ad hoc subcommittees are used, theythat would report to the full Committee.
: 14. Recordkeeping:
The Committee records will be handled in accordance with General Records Schedule 6.2 and approved NRC records disposition schedules. These records shall be available for public inspection and copying , subject to the Freedom of Information Act, 5 U.S .C.
552.
: 15. Filing date:
Month XX, 2020 Russell E. Chazell Federal Advisory Committee Management Officer Office of the Secretary}}

Latest revision as of 01:16, 2 March 2020

VR-COMSECY-20-0001: Renewal of Advisory Committee on the Medical Uses of Isotopes (ACMUI) Charter
ML20035D215
Person / Time
Issue date: 01/31/2020
From: Commissioners
NRC/OCM
To: Annette Vietti-Cook
NRC/SECY
References
COMSECY-20-0001 VR-COMSECY-20-0001
Download: ML20035D215 (12)


Text

f RESPONSE SHEET TO: Annette Vietti-Cook, Secretary FROM: CHAIRMAN SVINICKI

SUBJECT:

COMSECY-20-0001: Renewal of Advisory Committee on Medical Isotopes (ACMUI) Charter Approved XX Disapproved_ Abstain _ Not Participating _

Comments: Below XX Attached XX None I approve the renewal of the charter of the Advisory Committee on the Medical Uses of Isotopes, subject to the additional edits reflected in the attached version .

01,Z J ,2020 DATE Entered on "STARS" Yes __L_ No_

KLS Edits UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES

1. Committee's Official Designation {Title):

Advisory Committee on the Medical Uses of Isotopes (Committee or ACMUI)

2. Authority:

The committee is established pursuant to 42 United States Code (U .S.C) §2201 as an NRC discretionary committee in accordance with the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App.

3. Objectives and Scope of Activities:

The Committee provides advice, as requested by the Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST), Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy.

4. Description of Duties:

The Committee comments on changes to NRC regulations and guidance; evaluates certain non-routine uses of radioactive material; provides technical assistance in licensing, inspection, and enforcement cases; and brings key issues to the attention of the agency for appropriate action. The Committee members may also serve as medical consultants to the Director, MSST, as requested.

5. Official to Whom this Committee Reports:

Director, Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington , DC 20555

6. Agency Responsible for Providing Necessary Support to this Committee:

U.S. Nuclear Regulatory Commission.

7. Estimated Annual Operating Costs and Staff Years:

Approximately 13 members utilize 1.84 FTE (includes approximately 1.13 FTE in NRC staff support and 0.71 FTE for ACMUI member compensation and travel expenses), and

$337,000.

8. Designated Federal Officer:

A full time NRC employee from the Division of Materials Safety, Security, State, and Tribal Programs will serve as the Designated Federal Officer (DFO). The DFO will

approve or call all of the advisory committee and subcommittee meetings, prepare and approve all meeting agendas, attend all committee and subcommittee meetings, adjourn any meeting when the DFO determines adjournment to be in the public interest, and chair meetings when directed to do so by the Director, MSST.

9. Estimated Number of Meetings per Year:

Approximately five meetings per year, three of which are teleconferences.

10. Duration:

Continuing Committee

11. Termination:

Unless renewed by appropriate action, the Committee will terminate two-years from the date this charter is filed.

12. Membership and Designation:

Members are appointed by the Director, NMSS as Special Government Employees. The membership of the Committee +s-comprise.§.a approximatelyef 13 members, including health care professionals of diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration , and patient care advocacy.

13. Subcommittees:

The Committee may create subcommittees that report to the full committee. The Committee does not have standing subcommittees; if ad hoc subcommittees are used, they would report to the full Committee.

14. Recordkeeping:

The Committee records will be handled in accordance with General Records Schedule 6.2 and approved NRC records disposition schedules. These records shall be available for public inspection and copying, subject to the Freedom of Information Act, 5 U.S.C.

552.

15. Filing date:

Month XX, 2020 Russell E. Chazell Federal Advisory Committee Management Officer Office of the Secretary

RESPONSE SHEET TO: Annette Vietti-Cook, Secretary FROM: Commissioner Baran

SUBJECT:

COMSECY-20-0001: Renewal of Advisory Committee on Medical Isotopes (ACMUI) Charter Approved X Disapproved _ _ Abstain _ _ Not Participating COMMENTS: Below X Attached X None I approve the renewal of the updated Advisory Committee on the Medical Uses of Isotopes charter for a period of two years , subject to the attached edits.

Entered in "STARS" Yes X No DATE

UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON MEDICAL USES OF ISOTOPES

1. Committee's Official Designation (Title):

Advisory Committee on the Medical Uses of Isotopes (Committee or ACMUI}

2. Authority:

The committee is established pursuant to 42 United States Code (U .S.C) §2201 as an NRC discretionary committee in accordance with the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App.

3. Objectives and Scope of Activities:

The Committee provides advice, as requested by the Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST), Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy.

4. Description of Duties:

The Committee comments on changes to relevant NRC regulations and guidance; evaluates certain non-routine uses of radioactive material; provides technical assistance in licensing , inspection , and enforcement cases; and brings key issues to the attention of the agency for appropriate action . The Committee members may also serve as medical consultants to the Director, MSST, as requested .

5. Official to Whom this Committee Reports:

Director, Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington , DC 20555

6. Agency Responsible for Providing Necessary Support to this Committee:

U.S. Nuclear Regulatory Commission .

7. Estimated Annual Operating Costs and Staff Years:

Approximately 13 members utilize 1.84 FTE (includes approximately 1.13 FTE in NRC staff support and 0.71 FTE for ACMUI member compensation and travel expenses), and

$337,000.

8. Designated Federal Officer:

A full time NRC employee from the Division of Materials Safety, Security, State, and Triba l Programs will serve as the Designated Federal Officer (DFO). The DFO will

approve or call all of the advisory committee meetings, prepare and approve all meeting agendas, attend all committee meetings, adjourn any meeting when the DFO determines adjournment to be in the public interest, and chair meetings when directed to do so by the Director, MSST.

9. Estimated Number of Meetings per Year:

Approximately five meetings per year, three of which are teleconferences.

10. Duration:

Continuing Committee

11. Termination:

Unless renewed by appropriate action, the Committee will terminate two-years from the date this charter is filed.

12. Membership and Designation:

Members are appointed by the Director, NMSS as Special Government Employees. The membership of the Committee is comprised of 13 members, including health care professionals of diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy.

13. Subcommittees:

The Committee does not have standing subcommittees; if ad hoc subcommittees are used, they would report to the full Committee.

14. Recordkeeping:

The Committee records will be handled in accordance with General Records Schedule 6.2 and approved NRC records disposition schedules. These records shall be available for public inspection and copying , subject to the Freedom of Information Act, 5 U.S.C.

552.

15. Filing date:

Month XX, 2020 Russell E. Chazell Federal Advisory Committee Management Officer Office of the Secretary

RESPONSE SHEET TO: Annette Vietti-Cook, Secretary FROM: Commissioner Caputo

SUBJECT:

COMSECY-20-0001: Renewal of Advisory Committee on Medical Isotopes (ACM UI) Charter Approved _XX_ Disapproved _ Abstain _ Not Participating _

Comments: Below Attached _XX_ None I approve the updated charter for the Advisory Committee on the Medical Use of Isotopes, subject to the attached edits.

Entered in STARS Yes X No DATE

AC Edits on COMSECY-20-0001 UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES

1. Committee's Official Designation (Title):

Advisory Committee on the Medical Uses of Isotopes (Committee or ACMUI)

2. Authority:

The committee is established pursuant to 42 United States Code (U.S.C) §2201 as an NRC discretionary committee in accordance with the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App.

3. Objectives and Scope of Activities:

The Committee serves in an advisory role and provides advice, as requested by the Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST),

Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy.

4. Description of Duties:

The Committee comments on changes to NRC regulations and guidance; evaluates certain non-routine uses of radioactive material; provides technical assistance in licensing, inspection, and enforcement cases; and brings key issues to the attention of the agency for appropriate action. The Committee members may also serve as medical consultants to the Director, MSST, as requested.

5. Official to Whom this Committee Reports:

Director, Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington, DC 20555

6. Agency Responsible for Providing Necessary Support to this Committee:

U.S. Nuclear Regulatory Commission.

7. Estimated Annual Operating Costs and Staff Years:

Approximately 13 members utilize 1.84 FTE (includes approximately 1, 13 FTE in NRC staff support and 0.71 FTE for ACMUI member compensation and travel expenses), and

$337,000.

8. Designated Federal Officer:

A full time NRC employee from the Division of Materials Safety, Security, State, and Tribal Programs will serve as the Designated Federal Officer (DFO). The DFO will approve or call all of the advisory committee and subcommittee meetings, prepare and approve all meeting agendas, attend all committee and subcommittee meetings, adjourn any meeting when the DFO determines adjournment to be in the public interest, and chair meetings when directed to do so by the Director, MSST.

9. Estimated Number of Meetings per Year:

Approximately five meetings per year, three of which are teleconferences.

10. Duration:

Continuing Committee

11. Termination:

Unless renewed by appropriate action, the Committee will terminate two-years from the date this charter is filed.

12. Membership and Designation:

Members are appointed by the Director, NMSS as Special Government Employees. The membership of the Committee i&-comprise§.d approximately-et 13 members, including health care professionals of diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy.

13. Subcommittees:

The Committee does not have standing subcommittees, but has the authority to create subcommittees. which must report back to the full Committee and must not provide advice or work prod ucts directly to the agency. does not have standing subcommittees; if ad hoc subcommittees are used, they would report to the full Committee.

14. Recordkeeping:

The Committee records will be handled in accordance with General Records Schedule 6.2 and approved NRC records disposition schedules. These records shall be available for public inspection and copying, subject to the Freedom of Information Act, 5 U.S.C.

552.

15. Filing date:

Month XX, 2020 Russell E. Chazell Federal Advisory Committee Management Officer Office of the Secretary

RESPONSE SHEET TO: Annette Vietti-Cook, Secretary FROM: Commissioner Wright

SUBJECT:

COMSECY-20-0001: Renewal of Advisory Committee on Medical Isotopes (ACMUI) Charter Approved _x__ Disapproved _ Abstain _ Not Participating _

Comments: Below X Attached X None I approve the renewal of the Advisory Committee on the Medical Uses of Isotopes charter for a period of two years, subject to the attached edits.

Entered in STARS Yes 7 No- - -

~.cqJ SIGNATURE 01 /?.-'1-- /zo~o DATE '

DAW Edits UNITED STATES NUCLEAR REGULATORY COMMISSION CHARTER FOR THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES

1. Committee's Official Designation (Title):

Advisory Committee on the Medical Uses of Isotopes (Committee or ACMUI)

2. Authority:

The committee is established pursuant to 42 United States Code (U.S.C) §2201 as an NRC discretionary committee in accordance with the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App.

3. Objectives and Scope of Activities:

The Committee provides advice, as requested by the Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST), Office of Nuclear Material Safety and Safeguards (NMSS), on policy and technical issues that arise in regulating the medical use of byproduct material for diagnosis and therapy.

4. Description of Duties:

The Committee comments on changes to NRC regulations and guidance; evaluates certain non-routine uses of radioactive material; provides technical assistance in licensing, inspection, and enforcement cases; and brings key issues to the attention of the agency for appropriate action. The Committee members may also serve as medical consultants to the Director, MSST, as requested.

5. Official to Whom this Committee Reports:

Director, Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission Washington, DC 20555

6. Agency Responsible for Providing Necessary Support to this Committee:

Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards U.S. Nuclear Regulatory Commission.

7. Estimated Annual Operating Costs and Staff Years:

Approximately 13 members utilize 1.84 FTE (includes approximately 1.13 FTE in NRC staff support and 0.71 FTE for ACMUI member compensation and travel expenses), and

$337,000.

8. Designated Federal Officer:

A full time NRC employee from the Division of Materials Safety, Security, State, and Tribal Programs will serve as the Designated Federal Officer (DFO). The DFO will approve or call all of the advisory committee and subcommittee meetings, prepare and approve all meeting agendas , attend all committee and subcommittee meetings, adjourn any meeting when the DFO determines adjournment to be in the public interest, and chair meetings when directed to do so by the Director, MSST.

9. Estimated Number of Meetings per Year:

Approximately five meetings per year, three of which are teleconferences.

10. Duration:

Continuing Committee

11. Termination:

Unless renewed by appropriate action, the Committee will terminate two-years from the date this charter is filed.

12. Membership and Designation:

Members are appointed by the Director, NMSS as Special Government Employees. The membership of the Committee is composedfisee of 13 members, including health care professionals of diverse specialties who represent diagnostic and therapeutic applications of medicine, medical administration, and patient care advocacy.

13. Subcommittees:

The Committee does not have standing subcommittees. The full Committee may create~

  1. ad hoc subcommittees are used, theythat would report to the full Committee.
14. Recordkeeping:

The Committee records will be handled in accordance with General Records Schedule 6.2 and approved NRC records disposition schedules. These records shall be available for public inspection and copying , subject to the Freedom of Information Act, 5 U.S .C.

552.

15. Filing date:

Month XX, 2020 Russell E. Chazell Federal Advisory Committee Management Officer Office of the Secretary